NEW YORK (GenomeWeb News) – Helicos BioSciences said today that it has received an order for its Helicos Genetic Analysis System from an unnamed cancer research center in the US.

The order is the second for the firm’s flagship DNA sequencing platform since its launch earlier this year. The first customer, genomics services firm Expression Analysis, purchased a Helicos GAS in February.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.